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Collecting health information from patients is probably one
of the most ancient medical acts. The Hippocratic Corpus
was a compendium of medical records from Ancient Greece
and one of the first attempts to classify diseases according to
symptoms and observations.
Over the years, health records have been mainly used in
paper format to document individual patient characteristics,
to keep track of treatments, and to report patient outcomes.
Nowadays, as medical care is gettingmore andmore complex
and personalized, the recent advances and uses of infor-
mation technologies enable capturing, processing, storing,
and mining patient-level data in order to quickly extract
meaningful clinical information and medical knowledge for
clinical decision making and to further personalize health
care. With their widespread use, Electronic Health Records
(EHRs) have become a very important tool from which
new services can be provided. This major breakthrough is
already starting to transform research and development of
innovative health products by enhancing and speeding up
existing processes. This is because EHR data can be used to
rapidly optimise clinical protocol designs, to better identify
and faster recruit eligible patients for clinical trials, and to
foster new, efficient ways of collecting data during clinical
study conduct and improve the detection and reporting of
serious adverse events.
Despite available technologies, numerous challenges
remainwhich still require significant efforts and time: ethical,
legal, data privacy issues, information technology systems
integration, optimal interoperability for a seamless and trust-
worthy data exchange, and so forth.
Importantly, major innovations such as developing best
in class and seamless EHR-enabled clinical data exchange
systems require building awareness and trust with multiple
stakeholders in order to maximize the expected benefits,
as well as societal acceptance from patients, health care
providers, governmental bodies, and clinical trial sponsors.
In particular, clinical research investigators and sponsors
have long been using conventional clinical research processes
that rely more upon ad hoc case finding and ploughing
through large numbers of paper records. They will thus
require special attention, including the development and
dissemination of customized value propositions that explain
and evidence innovative EHR-based clinical research plat-
forms, how these compare with existing practices, and which
qualitative and quantitative benefits they can deliver in order
to facilitate adoption and large scale implementation.
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EHRs offer an unprecedented opportunity, as well as tech-
nological challenges, to change the current clinical research
paradigm, including the following:
(1) Patient databases are growing rapidly and are becom-
ing more accessible.
(2) The diversity of health records is important, covering
all kinds of populations and health conditions.
(3) EHRs are heterogeneous, which makes interoper-
ability (seamless data exchange) and integration of
information a challenging task.
(4) For a particular reuse of EHRs, only a selection of key
parameters (data items) might be useful for clinical
research.
(5) EHRs are dynamic: the monitoring of the changes
could become important features for many research
applications.
(6) The use of EHR data for clinical research could speed
up the patient recruitment phase, reduce the number
of protocol amendments, improve the efficiency of
major parts of the clinical trial process, and reduce
costs.
(7) EHRs offer many opportunities for data mining, such
as to extract original meaningful information from a
large set of patients or populations.
Given the growing demand worldwide for clinical evi-
dence (including from real-world contexts), as well as the
formidable challenges in clinical research today (including
costly protocol amendments, significant delays in patient
recruitment, time-consuming and redundant clinical data
entry in appropriate data management systems, and the
escalation in research and development costs), the question
is not so much if clinical research will use these new concepts
in current practice and benefit from reusing EHR data, but
when.
As more and more applied research domains are now
exploring how to use electronic platforms to facilitate key
clinical research tasks, and considering the inexorable trend
towards modernising clinical research models to create,
deliver, and capture more value and benefits, it appears to
be good timing to provide a scientific overview on the most
advanced research and developments in this field in the frame
of a special issue.
This special issue provides an opportunity to present
the latest scientific contributions and technological develop-
ments in this emerging field that can be derived from the
research use of EHR data.
The objectives of this special issue are twofold:
(1) For the first time, to bring together and to present
some of the latest research and development efforts in
this field, including technological R&D, surveys, and
pilot studies.
(2) To support more and focused research activities in
this domain. Given the large number of clinical trials
worldwide, the next challenge will naturally be to
ensure a seamless and sustainable deployment of
these advanced and trustworthy interoperable plat-
forms in order to enable the reuse of EHR data at the
global level.
There is no doubt that the original articles published in this
special issue already evidence this emerging reality for the
future of clinical research, thanks to the contributions of a
broad number of highly experienced and specialized authors
in this field. The presented articles address a wide range
of perspectives and compile the most promising research
findings and the latest developments.
As EHRs will continue to have a significant and posi-
tive impact on state-of-the-art clinical development, we are
confident that this special issue will stimulate further ideas
and research for enhancing, speeding up, and optimising
clinical research worldwide, towards delivering effective and
safe innovative medicines to health care faster, to the benefits
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